Effect of prevention of lung inflation on metamorphosis and respiration in the developing bullfrog tadpole, Rana catesbeiana.
We tested the hypothesis that respiratory development would be retarded in tadpoles reared in aquaria in which a barrier prevented access to the air-water interface. To test this hypothesis, we examined swimming behavior and respiration in intact tadpoles and gill and lung respiratory activity and central chemosensory responses in an in vitro brainstem preparation. The "barrier" tadpoles had significantly lower resting gill frequencies and higher lung breath attempts than control tadpoles at the same metamorphic stage. Control tadpoles swam greater distances and spent more time in the upper one third of the aquaria, while barrier tadpoles spent significantly more time at the bottom of the aquaria. There was significantly greater mortality for barrier tadpoles compared to control animals in the earliest and latest metamorphic stages. Mean body weight was significantly greater, and metamorphic rate was reduced in barrier tadpoles. Neither control nor barrier tadpole brainstem preparations demonstrated a gill ventilatory response to CO(2); however, both control and barrier preparations possessed significant lung frequency responses to central CO(2) chemoreceptor stimulation. Bath application of the GABA(A) and glycine receptor antagonists, bicuculline and strychnine, had greater effects on control tadpole gill burst activity and produced a similar large-amplitude bursting pattern in both control and barrier tadpoles, that was insensitive to CO(2) chemoreceptor stimulation. We conclude that development of the respiratory pattern was perturbed by the barrier, but the major effect was on gill ventilation rather than lung ventilation as we had expected.
Department of Biology, University of Texas at San Antonio, 6900 North Loop 1604 West, San Antonio, Texas 78249, USA. matthew.gdovin@utsa.edu
Matthew J
MJ
Gdovin
Vonnie V
VV
Jackson
Debora A
DA
Zamora
James C
JC
Leiter
D000818:Animals; D001640:Bicuculline / Q000494:pharmacology; D001835:Body Weight / Q000502:physiology; D002245:Carbon Dioxide / Q000494:pharmacology; D002628:Chemoreceptor Cells / Q000187:drug effects / Q000502:physiology; D025461:Feedback, Physiological; D005260:Female; D058787:GABA-A Receptor Antagonists; D005880:Gills / Q000187:drug effects / Q000294:innervation / Q000502:physiology; D007814:Larva / Q000254:growth & development* / Q000502:physiology; D008168:Lung / Q000187:drug effects / Q000294:innervation / Q000502:physiology*; D008176:Lung Volume Measurements; D008297:Male; D008675:Metamorphosis, Biological; D018377:Neurotransmitter Agents / Q000502:physiology; D012123:Pulmonary Ventilation; D011892:Rana catesbeiana / Q000254:growth & development* / Q000502:physiology; D018009:Receptors, Glycine / Q000037:antagonists & inhibitors; D012119:Respiration; D013331:Strychnine / Q000494:pharmacology; D013550:Swimming / Q000502:physiology
D058787:GABA-A Receptor Antagonists; D018377:Neurotransmitter Agents; D018009:Receptors, Glycine; D002245:Carbon Dioxide; D013331:Strychnine; D001640:Bicuculline